| |
The DHEA group
|
P-value
|
The DHEA plus climen group
|
P-value
|
|---|
|
Pre-treament
|
Post-treatment
|
Pre-treament
|
Post-treatment
|
|---|
|
AMH (ng/ml)
|
0.98 ± 0.72
|
1.24 ± 1.07
|
0.015
|
0.90 ± 0.66
|
1.14 ± 0.79
|
0.001
|
|
FSH(IU/L)
|
12.93 ± 7.02
|
10.03 ± 5.48
|
0.003
|
11.86 ± 5.29
|
9.08 ± 5.51
|
0.001
|
|
E2 (pmol/L)
|
181.53 ± 137.26
|
113.96 ± 70.00
|
0.001
|
160.65 ± 116.90
|
278.50 ± 135.80
|
0.000
|
|
High-FSH subgroups
|
|
AMH (ng/ml)
|
0.88 ± 0.65
|
0.99 ± 1.06
|
0.322
|
0.68 ± 0.58
|
0.89 ± 0.75
|
0.034
|
|
FSH (IU/L)
|
17.35 ± 6.34
|
11.84 ± 6.45
|
0.001
|
15.40 ± 4.00
|
10.56 ± 6.54
|
0.001
|
|
E2 (pmol/L)
|
155.70 ± 93.43
|
122.32 ± 79.44
|
0.070
|
120.35 ± 81.91
|
276.30 ± 139.76
|
0.000
|
|
Low-FSH subgroups
|
|
AMH (ng/ml)
|
1.11 ± 0.78
|
1.56 ± 1.01
|
0.002
|
1.18 ± 0.67
|
1.45 ± 0.74
|
0.004
|
|
FSH (IU/L)
|
7.24 ± 1.82
|
7.69 ± 2.49
|
0.445
|
7.13 ± 2.11
|
7.14 ± 2.87
|
0.982
|
|
E2 (pmol/L)
|
214.75 ± 174.96
|
103.21 ± 55.14
|
0.003
|
213.37 ± 135.26
|
281.53 ± 133.33
|
0.035
|
- Data are presented as mean ± SD (standard deviation) or percentage as appropriate. Subgroups were divided based on a basal FSH level cut-off of 10 mlU/ml
-
P <0.05 was considered as statistically significant
